AMG 334 20160172 Pediatric Migraine PK Study.
Public ClinicalTrials.gov record NCT03499119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I, Randomized, Open-label, Multiple-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of AMG 334 in Children and Adolescents With Migraine
Study identification
- NCT ID
- NCT03499119
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 53 participants
Conditions and interventions
Conditions
Interventions
- AMG 334 Dose 1 Drug
- AMG 334 Dose 2 Drug
- AMG 334 Dose 3 Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 3, 2018
- Primary completion
- Nov 22, 2021
- Completion
- Nov 22, 2021
- Last update posted
- May 27, 2024
2018 – 2021
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Childrens Hospital | Little Rock | Arkansas | 72202 | — |
| CarePoint | Englewood | Colorado | 80112 | — |
| New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Synergy Health | Bradenton | Florida | 34208 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| PANDA Neurology and Atlanta Headache Specialists | Atlanta | Georgia | 30328 | — |
| Riley Hosptial | Indianapolis | Indiana | 46202 | — |
| Clinical Research Institute Inc | Plymouth | Minnesota | 55441 | — |
| Childrens Mercy Hospital | Kansas City | Missouri | 64108 | — |
| Meridian Clinical Research | Hastings | Nebraska | 68901 | — |
| Dent Neurosciences Research Center | Amherst | New York | 14226 | — |
| State University of New York Upstate Medical University | Syracuse | New York | 13210 | — |
| Cincinnati Childrens Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Nationwide Childrens Hospital | Columbus | Ohio | 43205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03499119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2024 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03499119 live on ClinicalTrials.gov.